- Time, Friday, December 17, 2010 9:53 AM
The Food and Drug Administration will soon issue guidelines to pharmaceutical firms on how they can use social media to sell their drugs. Surprisingly, perhaps, it's the industry itself that has
pushed the FDA to do so.
Following Novo Nordisk's successful arrangement with racecar driver Charlie Kimball, a diabetic who tweets about the company's Levemir FlexPen, other companies are
eager to make their mark on Facebook, Twitter and the like.
Read the whole story at Time »